Uncategorized Archives - Report365 https://report365.in/category/uncategorized/ We've got it all Wed, 24 Aug 2022 12:38:10 +0000 en-GB hourly 1 https://wordpress.org/?v=6.7.2 https://report365.in/wp-content/uploads/2022/11/favicon.png Uncategorized Archives - Report365 https://report365.in/category/uncategorized/ 32 32 Jindal Steel & Power wins prestigious National CSR Award 2020 in Two Categories by the Ministry of Corporate Affairs https://report365.in/jindal-steel-power-wins-prestigious-national-csr-award-2020-in-two-categories-by-the-ministry-of-corporate-affairs/ Wed, 24 Aug 2022 06:17:48 +0000 https://report365.in/?p=3713 Declared as the winner in the category of ‘CSR in Aspirational Districts / Difficult Terrains’ (Eastern India) and ‘Contribution in National Priority Areas’ (Support to differently-abled) JSP has been selected for this coveted award after...

The post Jindal Steel & Power wins prestigious National CSR Award 2020 in Two Categories by the Ministry of Corporate Affairs appeared first on Report365.

]]>
Declared as the winner in the category of ‘CSR in Aspirational Districts / Difficult Terrains’ (Eastern India) and ‘Contribution in National Priority Areas’ (Support to differently-abled) JSP has been selected for this coveted award after a rigorous three-stage selection process initiated by the Ministry based on its prescribed systems of nominations  New Delhi, 22nd August 2022: Adding another feather in its cap, Jindal Steel & Power (JSP) has been selected for the prestigious National CSR Award 2020 in two categories by the Ministry of Corporate Affairs, Government of India.

As per an announcement recently by the Ministry of Corporate Affairs, Jindal Steel & Power, led by Shri Naveen Jindal, has been declared as the winner in the category of ‘CSR in Aspirational Districts / Difficult Terrains’ (Eastern India) and ‘Contribution in National Priority Areas’ (Support to differently-abled). JSP has been selected for this coveted award after a rigorous three-stage selection process initiated by the Ministry based on its prescribed systems of nominations by various Ministries, State Govt, three eminent Professional Institutes in India and Industry & Trade Chambers followed by Field verification and Grand Jury evaluation.

Commenting on the development, Chairman, JSP, Shri Naveen Jindal said, “We at JSP pursue Industry led inclusive development of our Nation partnering with the People and caring for the Planet. We have been implementing multidimensional Social development programmes under our CSR to improve the Quality of Life of the Community sustainably in the geography of our operational locations and beyond. The National CSR Award by the Ministry of Corporate Affair to JSP under two categories is indeed recognition of our philosophy of Passion for People. For us, it is always People First “.

Expressing her gratitude to the Government of India for recognizing Jindal Steel & Power with the National CSR Award, Smt. Shallu Jindal, Chairperson of JSP Foundation said, “We are humbled and encouraged that the Government of India has awarded us the highest recognition for our CSR programmes. As we emerge from the pandemic world, we are more aware of the crisis and needs that we are facing at various levels, in health, education, society and climate.

All our Programmes are completely aligned with the UN Sustainable Development Goals and aim to develop a more equitable and developed balance for the people in this country. This award will continue to motivate us to accelerate our efforts in implementing sustainable and inclusive development programmes across India.”

WADI, one of the innovative projects by JSP reviewed for the National CSR Award is an Agro Horti Silvipasture-based project implemented on 500 acres of hilly land benefiting the tribal populace of Chhattisgarh’s Tamnar block in Raigarh district. Under JSP Foundation’s Project Sneh, JSP has significantly contributed to major reduction of malnutrition in more than 1200 Children in Pallahara block in Angul district of Odisha. Both these interventions were reviewed in the multilayer selection process for the National CSR Award in the category of ‘CSR in Aspirational Districts / Difficult Terrains’ (Eastern India) apart from the Project Vastalya to control IMR and MMR and other projects of women empowerment in the tribal predominant region of Tamnar. Similarly the JSP’s flagship programme ‘Asha the Hope’ was reviewed for the award in the category of ‘Contribution in National Priority Areas’ (Support to differently-abled). Through this project, implemented under the umbrella support of JSP Foundation, the company works for the rehabilitation and empowerment of differently abled, particularly people in the formative age group.

Through its CSR arm JSP Foundation, JSP has been implementing multi-faceted sustainable social development initiatives around its operational areas in Odisha, Chhattisgarh and Jharkhand as well as across India with focus on consistent Improvement of the Human Development Index and associated socio-economic development measures in rural and tribal areas.  This is the announcement of CSR award for 2020 . The awards announced for the very first year of the award in 2019 was delivered by the HE President of India in Vigyan Bhawan , New Delhi.

The post Jindal Steel & Power wins prestigious National CSR Award 2020 in Two Categories by the Ministry of Corporate Affairs appeared first on Report365.

]]>
Marengo CIMS Hospital deeply acknowledges the exemplary courage of a family that opted to donate organs of their deceased family member to save four lives and restore sight in one https://report365.in/marengo-cims-hospital-deeply-acknowledges-the-exemplary-courage-of-a-family-that-opted-to-donate-organs-of-their-deceased-family-member-to-save-four-lives-and-restore-sight-in-one/ Fri, 12 Aug 2022 10:29:26 +0000 https://report365.in/?p=3617 Five organs were harvested and donated to multiple hospitals to save several lives Faith in humanity was restored by the family in showing immense courage and strength in donating the organs Marengo CIMS Hospital expresses...

The post Marengo CIMS Hospital deeply acknowledges the exemplary courage of a family that opted to donate organs of their deceased family member to save four lives and restore sight in one appeared first on Report365.

]]>
  • Five organs were harvested and donated to multiple hospitals to save several lives
  • Faith in humanity was restored by the family in showing immense courage and strength in donating the organs
  • Marengo CIMS Hospital expresses its heartfelt gratitude to the family who opted for the noble act of organ donation
  •  In an exemplary heroic and humanitarian act of nobility, a family which lost a young member to brain stroke decided to donate his organs to save several lives. Jayeshbhai Patel aged 35 years, was a factory worker. While working he collapsed and moving through various hospitals, the patient was brought to Marengo CIMS hospital where he was declared “Brain-dead”.

    The family rose above their grief and sorrow to embrace humanity and donate the deceased family member’s organs to save four lives and restore the sight of one. One kidney, two lungs, two corneas and one liver were retrieved. Post the retrieval process, the organs were reached to patients over four states. This was a show of immense courage and strength by the family to restore faith in humanity. At Marengo Asia Healthcare, we believe every minute counts, every life matters. The importance of timely decisions taken in organ donation is paramount in contributing significantly to saving lives.

    With Marengo CIMS Hospital armed with multiple organ transplant programs such as heart, lungs, kidney, and liver, the hospital is fast emerging as a preferred destination for organ transplants in India.

    Dr Raajiv Singhal, Founding Member, MD & CEO, Marengo Asia Healthcare said, “Marengo Asia Healthcare expresses our heartfelt gratitude to the patient’s family who went beyond their intense grief to think of several other patients whose lives could be saved by their act of organ donation. Our gratitude to many more such families who overcome their sorrow to save many lives by donating organs of their deceased family member. Many patients die every year due to lack of organ donation. Organ donation can save 500,000 lives in India each year. When families come forward with such humanitarian act, the fact that organ donation is picking up is reiterated. We encourage people to become a part of such humanitarian acts that can save thousands of lives every year.”

    The patient’s family said, “We realized the enormity of the number of lives that could be saved with this simple act of organ donation. We are encouraged by the fact that Jayeshbhai Patel will live through the people who have received his organs.”

    With increased organ donation we can save more and more lives. India happens to be one of the top countries in organ transplant in the world and yet, we lag our western counterparts. In India, a huge disparity between demand of organs for saving lives and the organs donated is witnessed consistently. The increasing numbers in organ donation in India is just about picking up, the awareness having been low and other reasons working as deterrents being religious beliefs, spiritual beliefs, and a negative mindset towards organ donation. The recent increase has been an outcome of increased awareness on the noble act.

    The post Marengo CIMS Hospital deeply acknowledges the exemplary courage of a family that opted to donate organs of their deceased family member to save four lives and restore sight in one appeared first on Report365.

    ]]>
    Allo Health announces appointment of Gaurav Gupta as CTO https://report365.in/allo-health-announces-appointment-of-gaurav-gupta-as-cto/ Wed, 03 Aug 2022 09:20:04 +0000 https://report365.in/?p=3561   Allo Health , India’s first digital health clinic for sexual wellness, announced the appointment of a technology leader Gaurav Gupta, as the CTO. In his new role, Gaurav will be responsible for leading and...

    The post Allo Health announces appointment of Gaurav Gupta as CTO appeared first on Report365.

    ]]>
     

    Allo Health , India’s first digital health clinic for sexual wellness, announced the appointment of a technology leader Gaurav Gupta, as the CTO. In his new role, Gaurav will be responsible for leading and spearheading new efforts to build the holistic care platform and scaling the business.

    Prior to this, Gaurav led the Labs and Billing team at Carbon Health, a chain of modern full-stack primary and urgent care clinics in the USA. Before Carbon, Gaurav was the CTO and Founding engineer at Eligible Inc, New York City, USA. Eligible provides a platform to securely process all insurance billing transactions, which powers some of the most innovative and advanced healthcare providers in the USA. As the CSO and security lead at Eligible, he extensively contributed to building highly available, scalable, reliable, secure, and HIPAA-compliant tech infrastructures. He was also instrumental in category expansion, automation in retail, and monetizing image inventory systems at Amazon. He was also part of the IBM Tivoli Solutions team, where he architected three solutions and published a patent with the US patent Office.

    Speaking on the appointment, Pranay Jivrajka, CEO – Allo Health said, “I am thrilled to have Gaurav join the team. His appointment comes at a time when Healthcare technology is rapidly changing the ways patients receive care in India. His experience in building and scaling world-class technology teams will be enormously helpful in creating a user-first platform that makes sexual wellness care accessible to all. Welcoming Gaurav to embrace the new wave of digital care delivery with Allo Health.”

    Speaking on his appointment, Gaurav Gupta, CTO, Allo Health said, Allo Health is revolutionizing the way Sexual wellness care is delivered by bringing doctors, operators, and engineers under one roof. The numerous taboos and discourses associated with sexual wellness in India prevent people from seeking help or even talking about it. We had our first baby through IVF last year, and since then, my wife and I have been raising awareness and breaking taboos associated with fertility treatment. I always wanted to return to India and improve healthcare discovery, delivery, and management here. I am thrilled to be a part of a team working relentlessly to bring a paradigm shift in care delivery through advanced technologies and services. We aim to normalize sexual wellness and make it accessible to all. I am ecstatic to join Allo Health and do my bit in building India’s first digital health clinic for sexual wellness.”

    Gaurav’s appointment underscores Allo Health’s mission to normalise sexual wellness for all and make sexual health care delivery accessible to all through technology. He is a graduate of IIT Varanasi with a recognized track record of conceptualising and realising scalable solutions across various industries like Health Tech, E-commerce, Tech Corps to name a few .

    The post Allo Health announces appointment of Gaurav Gupta as CTO appeared first on Report365.

    ]]>
    https://report365.in/2691-2/ Mon, 11 Apr 2022 04:25:14 +0000 https://report365.in/?p=2691 East Asia Pacific to reinvent,refresh and open new stores at more than 100 locations SINGAPORE, April 11, 2022 /PRNewswire/ — Levi Strauss & Co. (NYSE: LEVI) today announced ambitious plans to accelerate sustainable business growth and...

    The post appeared first on Report365.

    ]]>
    East Asia Pacific to reinvent,refresh and open new stores at more than 100 locations

    SINGAPORE, April 11, 2022 /PRNewswire/ — Levi Strauss & Co. (NYSE: LEVI) today announced ambitious plans to accelerate sustainable business growth and drive commercial success in the East Asia Pacific (EAP) region. Central to the growth strategy is the diversification of the business across geographies, apparel categories and distribution channels. Levi Strauss & Co. will be launching new stores and rolling out existing store refreshes and new in-store services throughout the region.
    Unable to view the image, Please provide a valid URL.

    Among the new stores to be launched this year are Levi’s® stores in countries including Japan, Australia, Indonesia, Singapore, Malaysia and Thailand. Levi Strauss & Co. will refurbish a number of retail stores and shop-in-shops into NextGen Indigo stores, offering an elevated store experience that uses digital tools to streamline the consumer journey, including installing LED portal entry archways and LED screens for marketing content. Select stores in the region will introduce in-store tailoring services to offer greater personalization. As the retail market finds its new equilibrium, Levi Strauss & Co. will focus on omnichannel engagement, leveraging the hybrid customer experience model.

    “We are committed to the future success of our business at every level and are reimagining what we do and how we win in today’s marketplace. At the same time, we are embracing the technologies of tomorrow to power innovation and better serve our customers and deliver greater value to stakeholders. We will do this by placing people at the heart of our business and through responsible practices because being a force for positive change is integral to being the world’s best apparel brand,” said Nuholt Huisamen, Managing Director and Senior Vice President at Levi Strauss & Co.

    Whilst drawing on the brand’s 169-year heritage to drive key category growth, Levi Strauss & Co. is redoubling its digital transformation efforts. The global leader in jeanswear will leverage digital, data and AI to stay ahead of trends, drive efficiency and innovation in the product creation process, deliver omnichannel offerings, claim its space in the direct-to-consumer (DTC) sphere, and ultimately enhance the consumer experience.

    As a company led by its core values of empathy, originality, integrity and courage and with a strong focus on diversity, equity and inclusion (DE&I), Levi Strauss & Co. has always been a destination for top talent. Throughout the pandemic, the company rolled out numerous initiatives to support employees in the offices, retail stores, distribution centres and manufacturing plants including providing flexible work arrangements, additional resources, and financial support. Through the Red Tab Foundation, the-first-of-its-kind employee hardship fund, the company provided approximately $2.4M in financial support to more than 1,800 individuals in 2021. Primarily funded by employees, shareholders and retirees, this unique concept helped our community with everyday hardships, natural disasters and the financial impacts of the COVID-19 pandemic. As part of its DTC strategy, the company also provided learning opportunities to existing staff to upskill themselves through training and development programs such as a Machine Learning Bootcamp to equip employees with the tools they need to thrive in a changing and increasingly digitalized economy.

    On the Environmental, Social and Governance (ESG) front, Levi Strauss & Co. has pegged its targets to measurable metrics and remains committed to responsible and sustainable practices outlined in its 2020 Sustainability Report. The company is on track to achieving its 2025 Water and Climate Action Strategy targets. Initiatives include Water<Less® finishing techniques that have enabled billions of liters of water to be saved; reducing emissions across the supply chain; driving innovation in sustainable materials and designs through Wellthread™; and advocating ethical consumerism through the Levi’s® Buy Better, Wear Longer campaign, these initiatives embody the company’s move to develop and implement circular products and practices

    Levi Strauss & Co. also continues to be a strong advocate for social justice issues and equality for women, marginalized ethnic groups and workers in the region. To support individuals in need, Levi Strauss & Co. contributes a portion of its earnings to improve the conditions in local communities. This legacy of giving began with a $5 donation from modest profits over 160 years ago. Additionally, the Levi Strauss Foundation has donated more than $340 million in proceeds and organized programs, employee volunteerism and public support. In 2021, employees donated over US$1.5 million and completed 12,871 volunteer hours.

    (Disclaimer: The above press release comes to you under an arrangement with PRNewswire India and this publication takes no editorial responsibility for the same)

    The post appeared first on Report365.

    ]]>
    https://report365.in/2078-2/ Wed, 22 Dec 2021 12:33:04 +0000 https://report365.in/?p=2078 The Gamaleya Center’s preliminary laboratory study shows that Sputnik V demonstrates high virus neutralizing activity (VNA) against the Omicron (B.1.1.529) variant and is expected to provide strong defense against severe disease and hospitalization. The study...

    The post appeared first on Report365.

    ]]>
    The Gamaleya Center’s preliminary laboratory study shows that Sputnik V demonstrates high virus neutralizing activity (VNA) against the Omicron (B.1.1.529) variant and is expected to provide strong defense against severe disease and hospitalization.

    The study was conducted using sera with a long period after vaccination (more than 6 months after vaccination) as an indicator of Sputnik V’s long-lasing protection.

    Sputnik V elicits strong and long-lasting T-cell response, and as 80% of epitopes in the spike protein are not affected by the mutations in the Omicron variant, Sputnik V is expected to provide long-lasting protection against severe disease by Omicron. Sputnik V’s long-lasting T-cell immunity contributes to 80% efficacy against Delta on months 6-8.

    Sputnik Light as a booster significantly increases virus neutralizing activity against Omicronbased on sera 2-3 months after revaccination. Virus neutralizing activity against Omicron 2-3 months after a Sputnik Light booster in this preliminary laboratory study is higher than VNA against the wild-type virus 6 months after Sputnik V vaccination. Based on these data the expected efficacy of Sputnik V with Sputnik Light booster against Omicron infection could be more than 80%, as Sputnik V showed efficacy of more than 80% against wild-type virus 6 month after vaccination. 100% of individuals revaccinated with Sputnik Light as a booster developed neutralizing antibodies against Omicron and demonstrated their high level 2-3 months after the revaccination.

    Sputnik Light booster is expected to provide strong protection against infection, severe disease and hospitalization by Omicron. Sputnik Light booster is recommended to strengthen efficacy of vaccines against Omicron. Boosting by Sputnik Light can strengthen and lengthen the quickly waning efficacy of many vaccines in light of combined Delta and Omicron challenge.

    Sputnik Light is a universal booster to other vaccines, including Sputnik V. In Argentina, a combination of Sputnik Light with other vaccines has demonstrated its effectiveness as a universal booster inducing stronger antibody and T-cell response compared to a two-shot homologous regimen. Sputnik V and Sputnik Light were developed on the basis of a safe and well-studied over 30 years technology and have not been associated with rare serious side effects as myocarditis or pericarditis.

    The highest safety and efficacy of Sputnik V and Sputnik Light was demonstrated in more than 30 studies and real-world data publications from more than 10 countries.

    Gamaleya National Research Center of Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), investor in Sputnik V and Sputnik Light vaccines, announced an article “Sputnik Light booster after Sputnik V vaccination induces robust neutralizing antibody response to B.1.1.529 (Omicron) SARS-CoV-2 variant” has been published in medRxiv (the preprint server for health sciences) and is available at:

    https://www.medrxiv.org/content/10.1101/2021.12.17.21267976v1

    The preliminary study by the Gamaleya Center has demonstrated that the Sputnik V vaccine and the one-shot Sputnik Light booster (based on human adenovirus serotype 26, the first component of Sputnik V) are effective against Omicron (B.1.1.529) variant of COVID, providing for better protection when compared to other vaccines. Heterologous boosting with Sputnik Light is the solution to increase other vaccines’ efficacy, including against Omicron, and extend the booster protection period.

    Sputnik Light as a booster significantly increases virus neutralizing activity against Omicron based on sera 2-3 months after revaccination and is a universal booster to other vaccines inducing stronger antibody and T-cell response.

    Sputnik Light booster is recommended to strengthen efficacy of vaccines against Omicron. Boosting by Sputnik Light as well as heterologous boosting can strengthen and lengthen the quickly waning efficacy of many vaccines in light of combined Delta and Omicron challenge.

    Sputnik Light has already been registered in more than 25 countries as a standalone vaccine and a universal booster to other vaccines helping to increase their efficacy (including in Argentina, UAE, Bahrain, Philippines, and San Marino). Sputnik V has been authorized in 71 countries with total population of over 4 billion people.

    Sputnik Light has already shown strong results used as a booster in mix & match trials in Argentina. A combination of Sputnik Light with vaccines produced by AstraZeneca, Sinopharm, Moderna and Cansino, conducted in 5 provinces (City and Province of Buenos Aires, as well as Córdoba, La Rioja and San Luis) has demonstrated that Sputnik Light induces stronger antibody and T-cell response as compared to homologous regimen (two shots of the same vaccine). Each “vaccine cocktail” combination with Sputnik Light provided higher antibody titer on the 14th day after administering a second dose when compared to original homogenous (same vaccine as first and second dose) regimens of each of the vaccines.

    Sputnik Light efficacy data:

    •Sputnik Light has been proven to be safe and highly effective by real-world vaccination data. In particular, data from the Ministry of Health of Buenos Aires (Argentina) has demonstrated standalone efficacy of Sputnik Light between 78.6-83.7% among the elderly (over 40,000 people of 60-79 years old), which is higher than that of many two-dose vaccines.

    •Findings by the Gamaleya Center based on data collected in Moscow have demonstrated Sputnik Light vaccine administered standalone has 70% efficacy against infection from the Delta variant of coronavirus during the first three months after vaccination. The vaccine is 75% effective among subjects under the age of 60. Sputnik V and Sputnik Light are based on a safe and effective human adenoviral vector platform and have not been associated with rare serious adverse events following vaccination, such as myocarditis or pericarditis.

    The post appeared first on Report365.

    ]]>